The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

Blood Cancer J. 2019 Feb 26;9(3):24. doi: 10.1038/s41408-019-0188-6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Synergism
  • Exportin 1 Protein
  • Humans
  • Karyopherins / antagonists & inhibitors*
  • Karyopherins / genetics
  • Karyopherins / metabolism
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / genetics
  • Lymphoma, Non-Hodgkin / metabolism
  • Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Karyopherins
  • Receptors, Cytoplasmic and Nuclear